BNA
MNPR icon

BankChampaign National Association’s Monopar Therapeutics MNPR Stock Holding History

BankChampaign National Association’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,510
Closed -$295K – 208
2025
Q4 		$295K Buy
+4,510
New +$368K 0.29% 115

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BankChampaign National Association's MNPR Position: Q1 2026 in Review

BankChampaign National Association sold out of Monopar Therapeutics (MNPR) in Q1 2026, closing a stake of 4,510 shares — an estimated $295K sold.

BankChampaign National Association first reported a position in MNPR in Q4 2025 and held it in 1 quarter. The position peaked at $295K in Q4 2025. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • BankChampaign National Association reported no remaining Monopar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • BankChampaign National Association sold 4,510 Monopar Therapeutics shares in Q1 2026, an estimated $295K.
  • BankChampaign National Association first reported a position in Monopar Therapeutics in Q4 2025 and held it in 1 quarter.
  • BankChampaign National Association's Monopar Therapeutics position peaked at $295K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on BankChampaign National Association's 13F filing for Q1 2026, filed 21 May 2026.